Oregon Public Employees Retirement Fund Allogene Therapeutics, Inc. Transaction History

Oregon Public Employees Retirement Fund

  • $4.78 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 25, 2022
SELL
$6.78 - $12.28 $267,511 - $484,519
-39,456 Closed
0 $0
Q4 2020

Feb 09, 2021
SELL
$25.24 - $43.45 $126,199 - $217,250
-5,000 Reduced 11.25%
39,456 $996,000
Q3 2020

Nov 03, 2020
BUY
$32.38 - $44.96 $1.44 Million - $2 Million
44,456 New
44,456 $1.68 Million

Others Institutions Holding ALLO

# of Institutions
164
Shares Held
106M
Call Options Held
97.5K
Put Options Held
45.6K
View Full List

About Allogene Therapeutics, Inc.

ALLO Quotes by TradingView
  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $335M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Oregon Public Employees Retirement Fund Portfolio

Follow Oregon Public Employees Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oregon Public Employees Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Oregon Public Employees Retirement Fund with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email